Ritter Pharmaceuticals (RTTR) Reports Q3 Loss of $0.40/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to Ritter Pharmaceuticals (RTTR) Reports Q3 Loss of $0.40/Share

Ritter Pharmaceuticals Provides Third Quarter 2015 Financial Results and Business Update

November 17, 2015 8:31 AM EST

LOS ANGELES--(BUSINESS WIRE)-- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (Ritter Pharmaceuticals or the Company), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today reported financial results and a business update for the third quarter ended September 30, 2015.

Recent Highlights

Closed initial public offering on June 29, 2015 generating gross proceeds of $20 million Strengthened senior leadership team with key appointments: William J. Sandborn, M.D. to Medical Advisory Board AnnKatrin Petersen-Jappelli, M.D., M.SC. as Chief Medical... More